The ATHENS TAVR Registry of Newer Generation Transfemoral Aortic Valves: 30-Day Outcomes
Transcatheter aortic valve replacement (TAVR) is a documented treatment for patients with symptomatic aortic stenosis who are at very high or prohibitive operative risk. We sought to investigate the outcomes of transfemoral procedures with the newer generation valves in four TAVR centres in Athens, Greece.
